“תהיה ירידה דרמטית בהכנסות אבל זה לא ישפיע על התפקוד”
גיל גרנות-מאיר שמנהל את ידע, חברת המסחור של מכון ויצמן, מתכונן ליום שבו הפטנט על הקופקסון יפקע באופן סופי, מדבר על היחסים עם החוקרים ומחפש מנועי צמיחה: "ידע תהיה בת…
Innovations and technologies for the aging population from Israel’s academia
As growing numbers of people live well into their 80s and 90s, age-related diseases and conditions, and the disability often associated with them, have become a massive public health concern.…
Medisafe aims past the ‘glorified alarm clock’ with intelligent adherence tech
by Carly Helfand | May 8, 2017 10:50am Adherence tech company Medisafe offers an intelligent feed feature as part of its interface that can function as a content publishing platform…
Mixiii Biomed 2017: 5 days to early registration deadline (ends on May 8th) & Conference program
AN OPPORTUNITY NOT TO BE MISSED – TAKE AN ACTIVE ROLE This is your last chance to take advantage of our Early Bird Registration rates which ends on Monday, May 8th.…
The conference will be attended by thousands of investors from around the world
*************** הכנס שיגיעו אליו אלפי משקיעים מהעולם - ואף לא מוסדי ישראלי כנס MIXII BIOMED הוא אחד הכנסים החשובים והמובילים בעולם בתחום מדעי החיים, שיוצגו בו טכנולוגיות עלית ישראליות בתחומים…
Patient centricity? Pharma’s there, expert says. It’s regulators who need to catch up
by Carly Helfand | Apr 17, 2017 Treato CEO Ido Hadari says patient centricity has become "a pillar in every life sciences and healthcare company out there." YEHUD, ISRAEL—Compare pharma's…
MeMed Wins $9.2M DTRA Contract for PoC IVD to Reduce Antibiotic Misuse
Israeli firm MeMed won a contract worth up to $9.2 million from the U.S. Department of Defense (DoD) Defense Threat Reduction Agency (DTRA) to complete the development of a…
Mixiii Biomed 2017: Early Bird Registration
AN OPPORTUNITY NOT TO BE MISSED – TAKE AN ACTIVE ROLE REGISTER NOW (Early Bird Registration Deadline May 08, 2017) Dear Colleagues, Mixiii Biomed 2017 is generating great interest, with registration…
Mixiii Biomed 2017: Only 7 days left to enter the Competition
Only 7 days left to register to MIXiii Biomed 2017 Start-up Area and Competition by: Israel Innovation Authority! For competition details please click here. Competition registration deadline: 10 APRIL 2017…
BiolineRx buys UK co Agalimmune
BiolineRx buys UK co Agalimmune 23 Mar, 2017 14:29 Gali Weinreb BiolineRx is paying $6 million upfront for Agalimmune, which has developed a new immunotherapy solution for treating cancer.…